Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INSIG2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | SYTL2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | DNAL1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | FAM72B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | BAMBI | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | COL1A2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | ZNF510 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | NUMBL | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | ADRA1A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |